Trial Title:
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
NCT ID:
NCT05946213
Condition:
Stage III Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Conditions: Official terms:
Prostatic Neoplasms
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Radiation
Intervention name:
External Beam Radiation Therapy
Description:
Undergo EBRT
Arm group label:
Arm II (EBRT)
Other name:
Definitive Radiation Therapy
Other name:
EBRT
Other name:
External Beam Radiation
Other name:
External Beam Radiotherapy
Other name:
External Beam Radiotherapy (conventional)
Other name:
External Beam RT
Other name:
external radiation
Other name:
External Radiation Therapy
Other name:
external-beam radiation
Other name:
Radiation, External Beam
Other name:
Teleradiotherapy
Other name:
Teletherapy
Other name:
Teletherapy Radiation
Intervention type:
Radiation
Intervention name:
Stereotactic Body Radiation Therapy
Description:
Undergo SBRT
Arm group label:
Arm I (SBRT)
Other name:
SABR
Other name:
SBRT
Other name:
Stereotactic Ablative Body Radiation Therapy
Summary:
This phase III trial compares stereotactic body radiation therapy (SBRT), (five
treatments over two weeks using a higher dose per treatment) to usual radiation therapy
(20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer.
SBRT uses special equipment to position a patient and deliver radiation to tumors with
high precision. This method may kill tumor cells with fewer doses over a shorter period
of time. This trial is evaluating if shorter duration radiation prevents cancer from
coming back as well as the usual radiation treatment.
Detailed description:
PRIMARY OBJECTIVE:
I. To compare metastasis-free survival, determined using conventional imaging, between
men with high-risk prostate cancer randomized to ultrahypofractionation (stereotactic
body radiation therapy [SBRT]) to those randomized to moderate hypofractionation and
conventional fractionation.
SECONDARY OBJECTIVES:
I. To compare physician-reported toxicity as measured by Common Terminology Criteria for
Adverse Events (CTCAE) version (v)5 between treatment arms.
II. To determine if ultrahypofractionation is non-inferior to moderate hypofractionation
and conventional fractionation with respect to patient-reported urinary function
(assessed by Expanded Prostate Cancer Index Composite [EPIC]-26 urinary domains).
III. To determine if ultrahypofractionation is non-inferior to moderate hypofractionation
and conventional fractionation with respect to patient-reported bowel function (assessed
by EPIC-26 bowel domain).
IV. To compare patient-reported fatigue (assessed by Patient Reported Outcomes
Measurement Information System [PROMIS]-Fatigue) between treatment arms.
V. To compare patient-reported treatment burden (assessed by COmprehensive Score for
financial Toxicity [COST]) between treatment arms.
VI. To compare failure-free survival between treatment arms. VII. To compare
metastasis-free survival based on molecular imaging between treatment arms.
VIII. To compare overall survival between treatment arms.
EXPLORATORY OBJECTIVES:
I. To compare patient-reported sexual function (assessed by EPIC-26 sexual domain)
between treatment arms.
II. To compare patient-reported quality of life (assessed by European Quality of Life
Five Dimension Five Level Scale Questionnaire [EQ-5D-5L]) between treatment arms.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients undergo SBRT for a total of 5 treatments over 2 weeks.
ARM II: Patients undergo external beam radiation treatment (EBRT) for 20-45 treatments
over 4 to 9 weeks.
Patients are followed up every 6 months for 5 years.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Pathologically (histologically or cytologically) proven diagnosis of adenocarcinoma
of prostate cancer
- High-risk disease defined as having at least one or more of the following:
- cT3a-T3b by digital exam or imaging (American Joint Committee on Cancer [AJCC]
8th edition [Ed.]) Note: cT4 by imaging or on digital rectal exam is not
allowed
- The patient's prostate specific antigen (PSA) > 20 ng/mL prior to starting ADT
Note: Patients taking a 5-alpha reductase inhibitor (ex finasteride or
dutasteride) are eligible. The baseline PSA value should be doubled for PSAs
taken while on 5-alpha reductase inhibitors
- Gleason Score of 8-10
- Pelvic node positive by conventional imaging with a short axis of at least 1.0
cm
- Prostate gland volume less than 100 cc prior to initiation of ADT as reported at
time of biopsy or by separate measure with ultrasound or other imaging modalities
including MRI or computed tomography (CT) scan
- No definitive clinical or radiologic evidence of metastatic disease outside of the
pelvic nodes (M1a, M1b or M1c) on conventional imaging (i.e. bone scan, CT scan,
MRI); Negative prostate-specific membrane antigen (PSMA) positron emission
tomography (PET) is an acceptable substitute
- Age >= 18
- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2
- No prior radiotherapy to the region of the study cancer that would result in overlap
of radiation therapy fields
- No prior radical prostatectomy
- Prior pharmacologic androgen ablation for prostate cancer is allowed only if the
onset of androgen ablation (both luteinizing hormone releasing hormone [LHRH]
agonist and oral anti-androgen) is =< 185 days prior to registration
- Patients enrolled in NRG-GU009 must be enrolled in NRG-GU013 prior to radiation
therapy treatment planning and start of radiation therapy
Gender:
Male
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Kaiser Permanente-Deer Valley Medical Center
Address:
City:
Antioch
Zip:
94531
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Dublin
Address:
City:
Dublin
Zip:
94568
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Fremont
Address:
City:
Fremont
Zip:
94538
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Fresno Cancer Center
Address:
City:
Fresno
Zip:
93720
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Fresno
Address:
City:
Fresno
Zip:
93720
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Modesto
Address:
City:
Modesto
Zip:
95356
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Oakland-Broadway
Address:
City:
Oakland
Zip:
94611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Oakland
Address:
City:
Oakland
Zip:
94611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
UC Irvine Health/Chao Family Comprehensive Cancer Center
Address:
City:
Orange
Zip:
92868
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-827-8839
Email:
ucstudy@uci.edu
Investigator:
Last name:
Steven N. Seyedin
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Rancho Cordova Cancer Center
Address:
City:
Rancho Cordova
Zip:
95670
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente- Marshall Medical Offices
Address:
City:
Redwood City
Zip:
94063
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Richmond
Address:
City:
Richmond
Zip:
94801
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Rohnert Park Cancer Center
Address:
City:
Rohnert Park
Zip:
94928
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Roseville
Address:
City:
Roseville
Zip:
95661
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
The Permanente Medical Group-Roseville Radiation Oncology
Address:
City:
Roseville
Zip:
95678
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Downtown Commons
Address:
City:
Sacramento
Zip:
95814
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-South Sacramento
Address:
City:
Sacramento
Zip:
95823
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
South Sacramento Cancer Center
Address:
City:
Sacramento
Zip:
95823
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-San Francisco
Address:
City:
San Francisco
Zip:
94115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Santa Teresa-San Jose
Address:
City:
San Jose
Zip:
95119
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente San Leandro
Address:
City:
San Leandro
Zip:
94577
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser San Rafael-Gallinas
Address:
City:
San Rafael
Zip:
94903
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Medical Center - Santa Clara
Address:
City:
Santa Clara
Zip:
95051
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Santa Rosa
Address:
City:
Santa Rosa
Zip:
95403
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Cancer Treatment Center
Address:
City:
South San Francisco
Zip:
94080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-South San Francisco
Address:
City:
South San Francisco
Zip:
94080
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Stockton
Address:
City:
Stockton
Zip:
95210
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente Medical Center-Vacaville
Address:
City:
Vacaville
Zip:
95688
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Vallejo
Address:
City:
Vallejo
Zip:
94589
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Kaiser Permanente-Walnut Creek
Address:
City:
Walnut Creek
Zip:
94596
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-642-4691
Email:
Kpoct@kp.org
Investigator:
Last name:
Samantha A. Seaward
Email:
Principal Investigator
Facility:
Name:
Helen F Graham Cancer Center
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Medical Oncology Hematology Consultants PA
Address:
City:
Newark
Zip:
19713
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Jupiter Medical Center
Address:
City:
Jupiter
Zip:
33458
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
561-745-5768
Investigator:
Last name:
Nathan Tennyson
Email:
Principal Investigator
Facility:
Name:
Northwestern University
Address:
City:
Chicago
Zip:
60611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
312-695-1301
Email:
cancer@northwestern.edu
Investigator:
Last name:
Sean Sachdev
Email:
Principal Investigator
Facility:
Name:
Decatur Memorial Hospital
Address:
City:
Decatur
Zip:
62526
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Kishwaukee
Address:
City:
DeKalb
Zip:
60115
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
Sean Sachdev
Email:
Principal Investigator
Facility:
Name:
Crossroads Cancer Center
Address:
City:
Effingham
Zip:
62401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-876-4762
Email:
morganthaler.jodi@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Delnor
Address:
City:
Geneva
Zip:
60134
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
Sean Sachdev
Email:
Principal Investigator
Facility:
Name:
Memorial Hospital East
Address:
City:
Shiloh
Zip:
62269
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-747-9912
Email:
dschwab@wustl.edu
Investigator:
Last name:
Hiram A. Gay
Email:
Principal Investigator
Facility:
Name:
Memorial Medical Center
Address:
City:
Springfield
Zip:
62781
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
217-528-7541
Email:
pallante.beth@mhsil.com
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Northwestern Medicine Cancer Center Warrenville
Address:
City:
Warrenville
Zip:
60555
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
630-352-5360
Email:
Donald.Smith3@nm.org
Investigator:
Last name:
Sean Sachdev
Email:
Principal Investigator
Facility:
Name:
McFarland Clinic - Ames
Address:
City:
Ames
Zip:
50010
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
515-239-4734
Email:
ksoder@mcfarlandclinic.com
Investigator:
Last name:
Joseph J. Merchant
Email:
Principal Investigator
Facility:
Name:
Saint Joseph Mercy Hospital
Address:
City:
Ann Arbor
Zip:
48106
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Saint Joseph Mercy Brighton
Address:
City:
Brighton
Zip:
48114
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Saint Joseph Mercy Canton
Address:
City:
Canton
Zip:
48188
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Saint Joseph Mercy Chelsea
Address:
City:
Chelsea
Zip:
48118
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Trinity Health Saint Mary Mercy Livonia Hospital
Address:
City:
Livonia
Zip:
48154
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
734-712-7251
Email:
MCRCwebsitecontactform@stjoeshealth.org
Investigator:
Last name:
Samir Narayan
Email:
Principal Investigator
Facility:
Name:
Saint Luke's Hospital of Duluth
Address:
City:
Duluth
Zip:
55805
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
218-249-7825
Email:
kdean@slhduluth.com
Investigator:
Last name:
Steven R. Bonin
Email:
Principal Investigator
Facility:
Name:
Saint Francis Medical Center
Address:
City:
Cape Girardeau
Zip:
63703
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
573-334-2230
Email:
sfmc@sfmc.net
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at West County Hospital
Address:
City:
Creve Coeur
Zip:
63141
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Hiram A. Gay
Email:
Principal Investigator
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Hiram A. Gay
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center-South County
Address:
City:
Saint Louis
Zip:
63129
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Hiram A. Gay
Email:
Principal Investigator
Facility:
Name:
Missouri Baptist Medical Center
Address:
City:
Saint Louis
Zip:
63131
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
314-996-5569
Investigator:
Last name:
Bryan A. Faller
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Christian Hospital
Address:
City:
Saint Louis
Zip:
63136
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Hiram A. Gay
Email:
Principal Investigator
Facility:
Name:
Siteman Cancer Center at Saint Peters Hospital
Address:
City:
Saint Peters
Zip:
63376
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
800-600-3606
Email:
info@siteman.wustl.edu
Investigator:
Last name:
Hiram A. Gay
Email:
Principal Investigator
Facility:
Name:
Benefis Healthcare- Sletten Cancer Institute
Address:
City:
Great Falls
Zip:
59405
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
406-969-6060
Email:
mccinfo@mtcancer.org
Investigator:
Last name:
John M. Schallenkamp
Email:
Principal Investigator
Facility:
Name:
Westchester Medical Center
Address:
City:
Valhalla
Zip:
10595
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
412-339-5294
Email:
Roster@nrgoncology.org
Investigator:
Last name:
Mark D. Hurwitz
Email:
Principal Investigator
Facility:
Name:
Aultman Health Foundation
Address:
City:
Canton
Zip:
44710
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
330-363-7274
Email:
ClinicalReserachDept@aultman.com
Investigator:
Last name:
Steven E. Olyejar
Email:
Principal Investigator
Facility:
Name:
University of Oklahoma Health Sciences Center
Address:
City:
Oklahoma City
Zip:
73104
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
405-271-8777
Email:
ou-clinical-trials@ouhsc.edu
Investigator:
Last name:
Tyler Gunter
Email:
Principal Investigator
Facility:
Name:
Christiana Care Health System-Concord Health Center
Address:
City:
Chadds Ford
Zip:
19317
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
302-623-4450
Email:
lbarone@christianacare.org
Investigator:
Last name:
Gregory A. Masters
Email:
Principal Investigator
Facility:
Name:
Reading Hospital
Address:
City:
West Reading
Zip:
19611
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
610-988-9323
Investigator:
Last name:
Michael L. Haas
Email:
Principal Investigator
Facility:
Name:
Langlade Hospital and Cancer Center
Address:
City:
Antigo
Zip:
54409
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-623-9869
Email:
Juli.Alford@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Ascension Saint Mary's Hospital
Address:
City:
Rhinelander
Zip:
54501
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Ascension Saint Michael's Hospital
Address:
City:
Stevens Point
Zip:
54481
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-847-2353
Email:
Beth.Knetter@aspirus.org
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Aspirus Regional Cancer Center
Address:
City:
Wausau
Zip:
54401
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
877-405-6866
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Facility:
Name:
Aspirus Cancer Care - Wisconsin Rapids
Address:
City:
Wisconsin Rapids
Zip:
54494
Country:
United States
Status:
Recruiting
Contact:
Last name:
Site Public Contact
Phone:
715-422-7718
Investigator:
Last name:
Andrew J. Huang
Email:
Principal Investigator
Start date:
November 13, 2023
Completion date:
March 31, 2041
Lead sponsor:
Agency:
NRG Oncology
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
NRG Oncology
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05946213
